[Bronchodilating action of salbutamol depending on route of administration]. / Dzialanie bronchodilatacyjne salbutamolu w zaleznosci od drogi podania leku.

The aim of this study was to demonstrate the differences in salbutamol's bronchodilating effect related to administration routes of the drug. Three different administration routes were assessed: salbutamol given by a MDI device, a nebulizer and intravenously. The following increases of FEV1 were seen after administration routes: MDI--12%, nebuliser--27%, intravenously--22%. These differences were statistically significant.